Renaissance Capital logo

BGLC News

US IPO Weekly Recap: ODDITY jumps 50% to become the IPO market’s latest beauty queen

ODD

Three IPOs priced this past week, led by the latest consumer success story, ODDITY Tech (ODD). DTC retailer ODDITY Tech priced above the raised range to raise $424 million at a $2.2 billion market cap. ODDITY’s current portfolio includes cosmetics and personal care brands IL MAKIAGE and SpoiledChild, though the company believes its data-...read more

Raw material and blood test supplier BioNexus prices Nasdaq uplisting at $4

BGLC

BioNexus Gene Lab, which distributes chemical products and provides non-invasive blood tests in Asia, raised $5 million by offering 1.3 million shares at $4. Prior to pricing, the company did not disclose a proposed range or price in its prospectus. The company was listed on the OTC. The company's subsidiary Chemrex focuses on the sale of chemical raw materials (mostly FRP) for...read more

US IPO Weekly Recap: Calendar is quieter than expected as more small IPOs join the pipeline

SODR

Two small issuers began trading this past week, only one of which was large enough to be included in our IPO stats, as several deals postponed (SODR, MGRX) or delayed (TRNR, INTS, NRXS). Two SPACs also priced. Eight IPOs submitted initial filings, the largest of which plans to raise just $29 million, as well as one SPAC. The most notable news came from the pipeline, with...read more

Raw material and blood test supplier BioNexus Gene Lab files for a $17 million Nasdaq uplisting

BGLC

BioNexus Gene Lab, which wholesales chemical products and provides non-invasive blood tests in Asia, filed on Tuesday with the SEC to raise up to $17 million in an initial public offering. The company is currently listed on the OTCQB under the symbol "BGLC". The company's subsidiary Chemrex focuses on the sale of chemical raw materials (mostly FRP) for manufacturing across several...read more

Archived Headlines